Modulation of the host flora

  • R. van Furth
  • H. F. L. Guiot
Review

Abstract

Modulation of the bacterial flora of patients with a high risk of acquiring an infection can be achieved in several ways. The approach used in the Leiden University Hospital is based on selective elimination of the aerobic bacteria in the oropharyngeal cavity and intestinal tract, leaving the anaerobic flora intact. This kind of selective modulation of the host flora has an advantage in that it does not affect the colonization resistance provided by bacterial antagonism, which prevents colonization by resistant but potentially pathogenic bacteria or fungi. The elimination of aerobic bacteria combined with nursing in protective isolation and consumption of food with few bacteria has led to a significant reduction of the incidence of major and fatal infections in patients during episodes of severe granulocytopenia. From these results it may be concluded that the objective of selective antibiotic modulation, namely, the prevention of infections, can be achieved with this approach.

Keywords

High Risk Internal Medicine Pathogenic Bacterium Intestinal Tract Aerobic Bacterium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gorbach, S. L., Barza, M., Giuliano, M., Jacobus, N. V. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. European Journal of Clinical Microbial Infectious Diseases 1988, 7: 98–102.Google Scholar
  2. 2.
    van der Waaij, D., de Vries Berghuis, J. M., Lekkerkerk van der Wees, J. E. C. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. Journal of Hygiene 1971, 69: 405–411.PubMedGoogle Scholar
  3. 3.
    van der Waaij, D., de Vries Berghuis, J. M., Lekkerkerk van der Wees, J. E. C. Colonization resistance of the digestive tract in mice during systemic antibiotic treatment. Journal of Hygiene 1972, 70: 605–610.PubMedGoogle Scholar
  4. 4.
    van der Waaij, D., Berghuis-de Vries, J. M. Selective elimination ofEnterobacteriaceae species from the digestive tract in mice and monkeys. Journal of Hygiene 1974, 77: 205–211.Google Scholar
  5. 5.
    Bergeim, O., Hanszen, A. H., Pincussen, L., Weiss, E. Relation of volatile fatty acids and hydrogen sulphide to the intestinal flora. Journal of Infectious Diseases 1941, 69: 155–166.Google Scholar
  6. 6.
    Bohnhoff, M., Miller, C. P., Martin, W. R. Resistance of the mouse's intestinal tract to experimentalSalmonella infection. I. Journal of Experimental Medicine 1964, 120: 805–816.CrossRefGoogle Scholar
  7. 7.
    Guiot, H. F. L. Volatile fatty acids and the selective growth inhibition of aerobic bacteria in the gut of rats. In: Sasaki, S., Ozawa, A., Hashimoto, K. (ed.): Recent advances in germfree research. Tokai University Press, Tokyo, 1981, p. 219–221.Google Scholar
  8. 8.
    Guiot, H. F. L. Role of competition for substrate in bacterial antagonism in the intestines. Infection and Immunity 1982, 38: 887–892.PubMedGoogle Scholar
  9. 9.
    Freter, R., Brickner, H., Fekete, J., Vickerman, M. M., Carey, K. E. Survival and implantation ofEscherichia coli in the intestinal tract. Infection and Immunity 1983, 39: 686–703.PubMedGoogle Scholar
  10. 10.
    van der Waaij, D., Berghuis-de Vries, J. M., Lekkerkerk van der Wees, J. E. C. Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice. Journal of Hygiene 1972, 70: 335–342.PubMedGoogle Scholar
  11. 11.
    Berg, R. D., Garlington, A. W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infection and Immunity 1979, 23: 403–404.PubMedGoogle Scholar
  12. 12.
    Steffen, E. K., Berg, R. D. Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. Infection and Immunity 1983, 39: 1252–1259.PubMedGoogle Scholar
  13. 13.
    Bodey, G. P., Buckley, M., Sathe, Y. S., Freireich, E. J. Quantitative relationship between circulating leukocytes and infections in patients with acute leukemia. Annals of Internal Medicine 1966, 64: 328–340.PubMedGoogle Scholar
  14. 14.
    van der Meer, J. W. M., Boekhout, M., Alleman, M. Infectious episodes in severely granulocytopenic patients. Infection 1979, 7: 171–175.CrossRefPubMedGoogle Scholar
  15. 15.
    Bodey, G. P., Rosenbaum, B. Effect of prophylactic measures of the microbial flora of patients in protected environment units. Medicine 1974, 53: 209–228.PubMedGoogle Scholar
  16. 16.
    Bodey, G. P. Current status of prophylaxis of infection with protected environments. American Journal of Medicine 1984, 76: 678–684.CrossRefPubMedGoogle Scholar
  17. 17.
    Schimpff, S. C. Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression. Annals of Internal Medicine 1980, 93: 358–361.PubMedGoogle Scholar
  18. 18.
    Ribas-Mundo, M., Graneda, A., Rozman, C. Evaluation of a protective environment in the management of granulocytopenic patients: a comparative study. Cancer 1981, 48: 419–424.PubMedGoogle Scholar
  19. 19.
    Kurrle, E., Abt, C., Bhaduri, S., Heimpel, H., Krieger, D., Vanek, E., Kubanec, B. Possibilities and problems of protective isolation and antimicrobial decontamination in man. Zentralblatt für Bakteriologie 1979, (A) 7 (Supplement): 63–66.Google Scholar
  20. 20.
    Guiot, H. F. L., van der Meer, J. W. M., Fibbe, W. E., de Planque, M. M., Zwaan, F. E., Biemond, I. The effects of the intestinal microflora of selective decontamination in patients undergoing allogeneic bone marrow transplantation. Experimental Hematology 1985, (Supplement 17) 13: 108–109.Google Scholar
  21. 21.
    Guiot, H. F. L.: The effect of the intestinal microflora of selective decontaminated patients on the severity of acute graft-versus-host disease. In: Gnotobiology and its applications. Proceedings of the IXth International Symposium on Gnotobiology, Versailles, France. Edition Fondation Marcel Mérieux, Lyon,Google Scholar
  22. 22.
    Petersen, F. B., Buckner, C. D., Clift, R. A., Nelsen, N., Counts, G. W., Meyers, J. D., Thomas, E. D. Infectious complication in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scandinavian Journal of Infectious Diseases 1987, 19: 559–567.PubMedGoogle Scholar
  23. 23.
    Guiot, H. F. L., van den Broek, P. J., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal flora of patients with acute non-lymphocytic leukemia: a double-blind, placebo-controlled study. Journal of Infectious Diseases 1983, 147: 615–623.PubMedGoogle Scholar
  24. 24.
    Guiot, H. F. L., van Furth, R. Partial antibiotic decontamination. British Medical Journal 1977, 1: 800–802.Google Scholar
  25. 25.
    Guiot, H. F. L., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. Journal of Infectious Diseases 1981, 143: 644–654.PubMedGoogle Scholar
  26. 26.
    van Furth, R., Nauta, E. H. Principles of antibiotic treatment. In: Elkerbout, F., Thomas, P., Zwaveling, A. (ed.): Cancer chemotherapy. Leiden University Press, Leiden, 1971, p. 387–394.Google Scholar
  27. 27.
    Bodey, G. P., Rodriquez, V., Chang, H., Narboni, G. Fever and infection in leukemic patients. Cancer 1978, 41: 1610–1621.PubMedGoogle Scholar
  28. 28.
    McChesney, E. W., Froelich, E. J., Lesher, G. Y., Crain, A. V. R., Rosi, D. Absorption, excretion, and metabolism of a new antibacterial agent, nalidixic acid. Toxicology and Applied Pharmacology 1964, 6: 292–309.CrossRefGoogle Scholar
  29. 29.
    Guiot, H. F. L., Helmig-Schurter, A. V., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures. Scandinavian Journal of Infectious Diseases 1986, 18: 153–160.PubMedGoogle Scholar
  30. 30.
    van der Meer, J. W. M., Guiot, H. F. L., van den Broek, P. J., van Furth, R. Infections in bone marrow transplant recipients. Seminars in Hematology 1984, 21: 123–140.PubMedGoogle Scholar
  31. 31.
    Willemze, R., Peters, W. G., van Hennik, M. B., Fibbe, W. E., Kootte, A. M. M., van Berkel, M., Lie, R., Rodenburg, C. J., Veltkamp, J. J. Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin's lymphoma. Scandinavian Journal of Haematology 1985, 34: 83–87.PubMedGoogle Scholar
  32. 32.
    Peters, W. G., Willemze, R., Colly, L. P., Guiot, H. F. L. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. Netherlands Journal of Medicine 1987, 30: 64–74.PubMedGoogle Scholar
  33. 33.
    Guiot, H. F. L., van den Broek, P. J., van der Meer, J. W. M., Peters, W. G., Willemze, R., van Furth, R. The association between streptococcal infection and interstitial pneumonia in chemotherapy and BMT. Bone Marrow Transplantation 1988, (Supplement 1) 3: 274.Google Scholar
  34. 34.
    Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J., Verhoef, J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute non-lymphocytic leukemia. Annals of Internal Medicine 1981, 95: 555–559.PubMedGoogle Scholar
  35. 35.
    Rozenberg-Arska, M., Dekker, A. W., Verhoef, J. Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria. Infection 1983, 11: 167–169.CrossRefPubMedGoogle Scholar
  36. 36.
    Dekker, A. W., Rozenberg-Arska, M., Verhoef, J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfa methoxazole and colistin. Annals of Internal Medicine 1987, 106: 7–12.PubMedGoogle Scholar
  37. 37.
    Piddock, L. J. V., Wijnands, W. J. A., Wise, R. Quinolone/ureidopenicillin cross-resistance. Lancet 1987, ii: 907.CrossRefGoogle Scholar
  38. 38.
    Sanders, C. C. Ciprofloxacin: in vitro activity, mechanism of action, and resistance. Reviews of Infectious Diseases 1988, 10: 516–527.PubMedGoogle Scholar
  39. 39.
    Armstrong, D. Protected environments are discomforting and expensive and do not offer meaningful protection. American Journal of Medicine 1984, 76: 685–689.CrossRefPubMedGoogle Scholar
  40. 40.
    Young, L. S. Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 93–97.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1989

Authors and Affiliations

  • R. van Furth
    • 1
  • H. F. L. Guiot
    • 1
  1. 1.Department of Infectious DiseasesUniversity HospitalLeidenThe Netherlands

Personalised recommendations